Literature DB >> 11870681

Familial amyotrophic lateral sclerosis.

Collette K Hand1, Guy A Rouleau.   

Abstract

The increasing complexity of the pathways implicated in the pathogenesis of familial amyotrophic lateral sclerosis (ALS) has stimulated intensive research in many directions. Genetic analysis of familial ALS has yielded six loci and one disease gene (SOD1), initially suggesting a role for free radicals in the disease process, although the mechanisms through which the mutant exerts toxicity and results in selective motor neuron death remain uncertain. Numerous studies have focused on structural elements of the affected cell, emphasizing the role of neurofilaments and peripherin and their functional disruption in disease. Other topics examined include cellular homeostasis of copper and calcium, particularly in the context of oxidative stress and the processes of protein aggregation, glutamate excitotoxicity, and apoptosis. It has become evident that there is considerable interplay between these mechanisms and, as the role of each is established, a common picture may emerge, enabling the development of more targeted therapies. This study discusses the main areas of investigation and reviews the findings. Copyright 2002 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11870681     DOI: 10.1002/mus.10001

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  28 in total

Review 1.  Complex genetics of amyotrophic lateral sclerosis.

Authors:  Catherine B Kunst
Journal:  Am J Hum Genet       Date:  2004-10-11       Impact factor: 11.025

2.  Oxidative stress and 17-alpha- and 17-beta-estradiol modulate neurofilaments differently.

Authors:  Keith Chiasson; Vicky Lahaie-Collins; Julie Bournival; Benoit Delapierre; Sylvie Gélinas; Maria-Grazia Martinoli
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 3.  Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.

Authors:  D Allan Butterfield; Marzia Perluigi; Tanea Reed; Tasneem Muharib; Christopher P Hughes; Renã A S Robinson; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2012-01-18       Impact factor: 8.401

Review 4.  4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies.

Authors:  Marzia Perluigi; Raffaella Coccia; D Allan Butterfield
Journal:  Antioxid Redox Signal       Date:  2012-02-15       Impact factor: 8.401

5.  Autophagy-linked FYVE protein (Alfy) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS).

Authors:  Huihui Han; Wanyi Wei; Weisong Duan; Yansu Guo; Yi Li; Jie Wang; Yue Bi; Chunyan Li
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-11-11       Impact factor: 2.416

Review 6.  Amyotrophic lateral sclerosis: progress and prospects for treatment.

Authors:  Michel Dib
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration.

Authors:  Caroline Rouaux; Natasa Jokic; Corinne Mbebi; Stephanie Boutillier; Jean-Philippe Loeffler; Anne-Laurence Boutillier
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

8.  Progression in primary lateral sclerosis: a prospective analysis.

Authors:  Mary Kay Floeter; Reversa Mills
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

9.  Dimer destabilization in superoxide dismutase may result in disease-causing properties: structures of motor neuron disease mutants.

Authors:  Michael A Hough; J Günter Grossmann; Svetlana V Antonyuk; Richard W Strange; Peter A Doucette; Jorge A Rodriguez; Lisa J Whitson; P John Hart; Lawrence J Hayward; Joan Selverstone Valentine; S Samar Hasnain
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-31       Impact factor: 11.205

10.  Influence of diagnostic categories, age, and gender on antioxidative defense and lipid peroxidation in skeletal muscle of patients with neuromuscular diseases.

Authors:  Hans-Joerg Stuerenburg; Birgit Stangneth; Alfried Kohlschütter; Barbara Finckh
Journal:  J Am Aging Assoc       Date:  2003-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.